What's new

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 18, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Da...

Next Article

PSUSA/00000408/202405

Related Posts

Summary of opinion: Keytruda, 27/02/2025 Positive

Summary of opinion: Keytruda, 27/02/2025 Positive

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

EMEA-003472-PIP01-23

EMEA-003472-PIP01-23

Feb 17, 2025  0